Malaysia PCT National Phase Entry: 30 Months, Form 2A and Examination

Direct answer: Malaysia PCT national phase

Application eligibility and national-phase purpose

Malaysia's PCT national phase requires a separate entry procedure before the Intellectual Property Corporation of Malaysia (MyIPO); the international filing alone does not create an examined Malaysian patent. MyIPO explains that national-phase entry is normally made within 30 months from the earliest priority date and requires the application materials and the prescribed fee through Form 2A. The filing decision should begin with that date, the language of the international application, the intended claims and whether Malaysia is commercially relevant.

MyIPO entry differs from international filing

A Malaysian national phase is not the same as making an international application through MyIPO as a receiving office. The first brings an existing PCT application into Malaysia; the second begins an international filing from an eligible applicant. Confusing these processes produces inaccurate fee estimates and procedural checklists.

Official reference: Applying for a Patent/Utility Innovation.

Determine entry deadline

Priority date and 30-month calculation

Build the national-phase deadline from the earliest valid priority date, checking the PCT request, WIPO records and all claimed priorities. MyIPO's official PCT guidance describes a 30-month national-phase window for Malaysia. Because time computation, exceptional relief and office procedure are legally consequential, resolve case-specific uncertainties against current official requirements rather than inferring that the more familiar 31-month deadline from another country applies.

Exception or restoration rules require checking

List each deadline against its consequence and proof. Do not mistake the date of the international search opinion, publication or demand for preliminary examination for the Malaysian entry deadline. If the apparent deadline is missed, avoid representing that a late form or payment will automatically restore the application: determine whether a relevant remedy exists and what evidence would be required.

MyIPO Form 2A filing documents

Applicant and international application data

MyIPO refers to national-phase fees paid using Form 2A. Prepare the PCT application number, international filing date, priority data, applicant identity and the application specification in the format required by the current Malaysian procedure. The office's online and manual filing instructions should be checked for whether the relevant service accepts the intended attachments or requires supporting authority documents.

Supporting document crosswalk for Form 2A

An effective prefiling comparison checks the title, inventor and applicant information against the international record, as well as any priority or assignment document needed locally. The minimum checklist is not merely “upload a PDF”: it should also identify the operative claims, description, drawings, abstract and translation or correction requirements, together with evidence that MyIPO accepted the national-phase entry.

English requirements and translation assessment

English copies and translation scope

MyIPO's PCT materials identify English as the language for national-phase application materials, so applicants should examine whether the international application and relevant claim documents already meet that requirement. If a source filing is in another language, obtain competent technical translation and ensure the translation corresponds to the version being entered. Claims should be reviewed for technical consistency, not translated in isolation from the description and figures.

Match amendments and original PCT records

A drafting issue can appear where the international text uses a technical term whose English equivalents differ across jurisdictions. Create a glossary for critical features and cross-check any amendment proposed for Malaysian examination against the disclosure on which the national-phase filing is based. When the translation scope is uncertain, identify the question for Malaysian agent confirmation rather than asserting an across-the-board requirement.

Official reference: Patent forms and fees.

2026 published fees and examination choices

Form 2A filing fee versus examination fees

The Malaysian filing cost depends on official MyIPO charges, the number and nature of services requested and the downstream examination plan. Form 2A is associated with entry, but national fees should be checked against the current fee schedule immediately before payment. Legal representation, translation, specification amendment and responding to examination reports are additional cost drivers. Do not present a fixed total cost without stating what is included.

Fee-source date and scenario components

The examination plan should cover when substantive examination or any available work-sharing request is relevant, what evidence is needed and how search results from related countries may help. MyIPO lists patent examination-cooperation mechanisms, but participation or eligibility cannot be assumed from the existence of a foreign patent. Put official fee references and procedural conditions next to any cost or acceleration discussion.

Claim and applicant formalities

Check local applicant, agency and document formalities

Check applicant naming, assignments, local agent status, authorization documents, claim language and document versions before submitting the national-phase request. If the PCT application has multiple applicants or a complex priority chain, identify who has entitlement in Malaysia and what evidence the agent requires. A technically excellent specification cannot compensate for an unresolved applicant identity or procedural issue.

Preserve original support for Malaysian claim changes

Claim amendments should be assessed against the original disclosure and local amendment standards. Do not treat claim scope accepted by the US or EPO as automatically acceptable in Malaysia. The case file should preserve the entered specification, original PCT documents, translations, prior-art documents and the rationale behind any subsequent changes.

Comparison with nearby ASEAN filing decisions

Compare Malaysia and Singapore only on distinct rules

Malaysia can be considered alongside Singapore, Indonesia, Thailand, Vietnam and other ASEAN jurisdictions, but there is no single ASEAN patent that makes national filings unnecessary. A regional market strategy should examine manufacturing sites, competitors, procurement chains, licensing partners and enforcement prospects before deciding where to bear national-phase cost. Language, examination, representative requirements and deadlines vary materially between offices.

Territory and language factors for applicants

The strongest comparison is a cost-and-outcome matrix: target customer exposure, potential infringement, filing deadline, translation burden, national fee, examination procedure and portfolio strategy. A company with manufacturing risk in Malaysia may prioritize it even if direct retail revenue is currently smaller than elsewhere. Country decisions should be tied to enforceable business interests rather than total population.

Official reference: Patent forms and fees.

Failure modes, prefiling checklist and next action

Required versus conditional documents

The final checklist should confirm the 30-month date, PCT bibliographic data, entered language, specification/claims, Form 2A, current fees, applicant and representative authority, any translations and proof of successful filing. Ask for an office acknowledgement and a docket for examination after entry. Keep formal payment evidence with the legal file.

Final filing and legal review checkpoint

Three frequent planning failures are using a deadline from a different national office, relying on a generic “PCT covers Malaysia” assumption, and budgeting only the initial filing charge. A professionally useful entry memorandum identifies what is confirmed by current MyIPO guidance, what requires local verification and the future prosecution costs or deadlines the applicant must anticipate.